Seroprevalence of Helicobacter pylori infection in cystic fibrosis and its cross-reactivity with anti-pseudomonas antibodies.
Seroprevalence of Helicobacter pylori infection in cystic fibrosis and its cross-reactivity with anti-pseudomonas antibodies.
复制标题
囊性纤维化中幽门螺杆菌感染的血清阳性率及其与抗假单胞菌抗体的交叉反应性。
DOI:
10.1097/00005176-200004000-00015
复制
发表时间:
2000
影响因子:
2.9
通讯作者:
Gold,BD
中科院分区:
文献类型:
--
作者:
Israel,NR;Khanna,B;Cutler,A;Perry,M;Caplan,D;Weatherly,M;Gold,BD
Background:The prevalence of Helicobacter pylori infection and its role in gastroduodenal disease in cystic fibrosis (CF) are controversial. Additionally, serologic determination of infection in this population may be inaccurate because of cross-reactivity with other bacterial species. The seroprevalence of H. pylori in a cohort of patients with CF and its cross-reactivity with Pseudomonas antibodies were investigated.Methods:A research enzyme-linked immunosorbent assay (ELISA), and three commercial serologic assays (PyloriStat; BioWhittaker, Walkersville, MD, USA; Flexsure; SmithKline Diagnostics, Inc., San Jose, CA, USA; and HM-CAP; EPI, Stony Brook, NY, USA) at three independent laboratories determined the seroprevalence of anti-H. pylori IgG antibodies in 70 patients with CF. Cross-reactivity between solid-phase H. pylori antigens and Pseudomonas antibodies was ascertained by a competitive inhibition assay, preadsorbing sera of patients with CF with whole cell proteins from different Pseudomonas species, and serum reanalysis by each assay. Western blot analysis before and after adsorption was performed to identify potential cross-reactive antigens.Results:The research ELISA, Flexsure, Pyloristat, and HM-CAP initially showed H. pylori seropositivity of 47%, 28%, 24%, and 37%, respectively. Postadsorption seropositivity declined to 8%, 0%, 0%, and 15%, respectively. All patients with research ELISA true-positive results were confirmed endoscopically to have H. pylori infection. Western blot analysis showed a 31-kDa H. pylori protein with antigenic epitopes common to both bacterial species.Conclusions:Cross-reactivity between solid-phase H. pylori antigens and anti-Pseudomonas antibodies occurs in patients with CF. A high index of suspicion should be assumed in evaluating results of serologic H. pylori tests in this population. Preadsorption of CF sera with Pseudomonas proteins should be used in serologic testing.
登录
查看更多内容
影响因子:
9.4
作者:
F. Mégraud;M.;F. Denis;A. Belbouri;D. Q. Hoa
通讯作者:
D. Q. Hoa
影响因子:
3.1
作者:
G. Döring;N. Høiby
通讯作者:
N. Høiby
DOI:
10.1099/00221287-133-1-163
发表时间:
1987
期刊:
Journal of general microbiology
影响因子:
--
作者:
D. Newell
通讯作者:
D. Newell
影响因子:
9.8
作者:
Marchildon, P;Balaban, DH;Peura, DA
通讯作者:
Peura, DA
影响因子:
3.1
作者:
G. Perez;J. Hopkins;M. Blaser
通讯作者:
M. Blaser